Nanotherapeutic Intervention in Photodynamic Therapy for Cancer

Overview

Journal ACS Omega

Publisher American Chemical Society

Specialty Chemistry

Date 2022 Dec 26

PMID 36570217

Authors

Asif Mohd Itoo

Milan Paul

Sri Ganga Padaga

Balaram Ghosh

Swati Biswas

Affiliations

Soon will be listed here.

Abstract

The clinical need for photodynamic therapy (PDT) has been growing for several decades. Notably, PDT is often used in oncology to treat a variety of tumors since it is a low-risk therapy with excellent selectivity, does not conflict with other therapies, and may be repeated as necessary. The mechanism of action of PDT is the photoactivation of a particular photosensitizer (PS) in a tumor microenvironment in the presence of oxygen. During PDT, cancer cells produce singlet oxygen (O) and reactive oxygen species (ROS) upon activation of PSs by irradiation, which efficiently kills the tumor. However, PDT's effectiveness in curing a deep-seated malignancy is constrained by three key reasons: a tumor's inadequate PS accumulation in tumor tissues, a hypoxic core with low oxygen content in solid tumors, and limited depth of light penetration. PDTs are therefore restricted to the management of thin and superficial cancers. With the development of nanotechnology, PDT's ability to penetrate deep tumor tissues and exert desired therapeutic effects has become a reality. However, further advancement in this field of research is necessary to address the challenges with PDT and ameliorate the therapeutic outcome. This review presents an overview of PSs, the mechanism of loading of PSs, nanomedicine-based solutions for enhancing PDT, and their biological applications including chemodynamic therapy, chemo-photodynamic therapy, PDT-electroporation, photodynamic-photothermal (PDT-PTT) therapy, and PDT-immunotherapy. Furthermore, the review discusses the mechanism of ROS generation in PDT advantages and challenges of PSs in PDT.

Citing Articles

Revolutionizing Cancer Immunotherapy: Emerging Nanotechnology-Driven Drug Delivery Systems for Enhanced Therapeutic Efficacy.

Theivendren P, Kunjiappan S, Pavadai P, Ravi K, Murugavel A, Dayalan A ACS Meas Sci Au. 2025; 5(1):31-55.

PMID: 39991031 PMC: 11843507. DOI: 10.1021/acsmeasuresciau.4c00062.

Green silver nanoparticles curcumin conjugate induced photodynamic therapy of lung cancer and lung cancer stem cells.

Kah G, Chandran R, Abrahamse H RSC Adv. 2025; 15(7):5020-5041.

PMID: 39957816 PMC: 11827557. DOI: 10.1039/d4ra06035k.

Advances in Nanotheranostic Systems for Concurrent Cancer Imaging and Therapy: An Overview of the Last 5 Years.

Lankoff A, Czerwinska M, Kruszewski M Molecules. 2025; 29(24.

PMID: 39770074 PMC: 11677634. DOI: 10.3390/molecules29245985.

Exploring the potential of 7,4'-di(diethylamino)flavylium as a novel photosensitizer for topical photodynamic therapy of skin cancer.

Correia P, Araujo P, Marto J, Ribeiro H, Mateus N, de Freitas V Sci Rep. 2024; 14(1):29535.

PMID: 39604502 PMC: 11603071. DOI: 10.1038/s41598-024-80860-x.

Preparation and effects of functionalized liposomes targeting breast cancer tumors using chemotherapy, phototherapy, and immunotherapy.

Zeng B, Pian L, Liu Y, Wang S, Wang N, Liu C J Nanobiotechnology. 2024; 22(1):558.

PMID: 39267061 PMC: 11391708. DOI: 10.1186/s12951-024-02838-1.

References

Wulf H, Al-Chaer R, Glud M, Philipsen P, Lerche C . A Skin Cancer Prophylaxis Study in Hairless Mice Using Methylene Blue, Riboflavin, and Methyl Aminolevulinate as Photosensitizing Agents in Photodynamic Therapy. Pharmaceuticals (Basel). 2021; 14(5). PMC: 8148192. DOI: 10.3390/ph14050433. View

Tang W, Xu H, Kopelman R, Philbert M . Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms. Photochem Photobiol. 2004; 81(2):242-9. DOI: 10.1562/2004-05-24-RA-176.1. View

Kumari P, Paul M, Bhatt H, Rompicharla S, Sarkar D, Ghosh B . Chlorin e6 Conjugated Methoxy-Poly(Ethylene Glycol)-Poly(D,L-Lactide) Glutathione Sensitive Micelles for Photodynamic Therapy. Pharm Res. 2020; 37(2):18. DOI: 10.1007/s11095-019-2750-0. View

Chen J, Xu Y, Gao Y, Yang D, Wang F, Zhang L . Nanoscale Organic-Inorganic Hybrid Photosensitizers for Highly Effective Photodynamic Cancer Therapy. ACS Appl Mater Interfaces. 2017; 10(1):248-255. DOI: 10.1021/acsami.7b15581. View

Rodriguez L, Vallecorsa P, Battah S, Di Venosa G, Calvo G, Mamone L . Aminolevulinic acid dendrimers in photodynamic treatment of cancer and atheromatous disease. Photochem Photobiol Sci. 2015; 14(9):1617-27. DOI: 10.1039/c5pp00126a. View

Maeda H, Wu J, Sawa T, Matsumura Y, Hori K . Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000; 65(1-2):271-84. DOI: 10.1016/s0168-3659(99)00248-5. View

Itoo A, Vemula S, Gupta M, Giram M, Kumar S, Ghosh B . Multifunctional graphene oxide nanoparticles for drug delivery in cancer. J Control Release. 2022; 350:26-59. DOI: 10.1016/j.jconrel.2022.08.011. View

Huang H, Pigula M, Fang Y, Hasan T . Immobilization of Photo-Immunoconjugates on Nanoparticles Leads to Enhanced Light-Activated Biological Effects. Small. 2018; :e1800236. PMC: 6312758. DOI: 10.1002/smll.201800236. View

Milane L, Duan Z, Amiji M . Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells. Mol Pharm. 2010; 8(1):185-203. PMC: 3817847. DOI: 10.1021/mp1002653. View

10.

Zhao Z, Shi S, Huang Y, Tang S, Chen X . Simultaneous photodynamic and photothermal therapy using photosensitizer-functionalized Pd nanosheets by single continuous wave laser. ACS Appl Mater Interfaces. 2014; 6(11):8878-85. DOI: 10.1021/am501608c. View

11.

Ding B, Shao S, Yu C, Teng B, Wang M, Cheng Z . Large-Pore Mesoporous-Silica-Coated Upconversion Nanoparticles as Multifunctional Immunoadjuvants with Ultrahigh Photosensitizer and Antigen Loading Efficiency for Improved Cancer Photodynamic Immunotherapy. Adv Mater. 2018; 30(52):e1802479. DOI: 10.1002/adma.201802479. View

12.

Shi J, Yu X, Wang L, Liu Y, Gao J, Zhang J . PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging. Biomaterials. 2013; 34(37):9666-77. DOI: 10.1016/j.biomaterials.2013.08.049. View

13.

Allison R . Photodynamic therapy: oncologic horizons. Future Oncol. 2013; 10(1):123-4. DOI: 10.2217/fon.13.176. View

14.

Neginskaya M, Berezhnaya E, Uzdensky A, Abramov A . Reactive Oxygen Species Produced by a Photodynamic Effect Induced Calcium Signal in Neurons and Astrocytes. Mol Neurobiol. 2017; 55(1):96-102. DOI: 10.1007/s12035-017-0721-1. View

15.

Dong Z, Feng L, Hao Y, Chen M, Gao M, Chao Y . Synthesis of Hollow Biomineralized CaCO-Polydopamine Nanoparticles for Multimodal Imaging-Guided Cancer Photodynamic Therapy with Reduced Skin Photosensitivity. J Am Chem Soc. 2018; 140(6):2165-2178. DOI: 10.1021/jacs.7b11036. View

16.

Lucky S, Soo K, Zhang Y . Nanoparticles in photodynamic therapy. Chem Rev. 2015; 115(4):1990-2042. DOI: 10.1021/cr5004198. View

17.

Hu C, Yu Y, Chao S, Zhu H, Pei Y, Chen L . A Supramolecular Photosensitizer System Based on Nano-Cu/ZIF-8 Capped with Water-Soluble Pillar[6]arene and Methylene Blue Host-Guest Complexations. Molecules. 2021; 26(13). PMC: 8271439. DOI: 10.3390/molecules26133878. View

18.

Wu W, Mao D, Hu F, Xu S, Chen C, Zhang C . A Highly Efficient and Photostable Photosensitizer with Near-Infrared Aggregation-Induced Emission for Image-Guided Photodynamic Anticancer Therapy. Adv Mater. 2017; 29(33). DOI: 10.1002/adma.201700548. View

19.

Powis G . Free radical formation by antitumor quinones. Free Radic Biol Med. 1989; 6(1):63-101. DOI: 10.1016/0891-5849(89)90162-7. View

20.

Yoon H, Koo H, Choi K, Lee S, Kim K, Kwon I . Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials. 2012; 33(15):3980-9. DOI: 10.1016/j.biomaterials.2012.02.016. View